LE WE PMID CA
AMD macular degeneration116AMD Altersabhaengige Makuladegeneration

AMD macular degeneration

Anecortave acetate

Apolipoprotein B

CNS (Stroke BASKET)

Drusen

ERS UFR (Diseases)

Eye (Retina BASKET)

Eye and orbita (Neovascularization)

Pegaptanib

Phototoxicity

Ranibizumab ttVEGF

2003  
1
Age related macular degeneration.
[12609947] BMJ 326(7387): 485-8 (2003)
2007  
2
An update of treatment options for neovascular age-related macular degeneration.
[18057435] Hong Kong Med J 13(6): 460-70 (2007)
2005  
3
Age-related macular degeneration.
[16235759] Ulster Med J 74(2): 82-92 (2005)
2003  
4
Age-related macular degeneration: evaluation and treatment.
[14686682] Cleve Clin J Med 70(12): 1017-8, 1020, 1023-5 passim (2003)
2006  
5
Ranibizumab in neovascular age-related macular degeneration.
[18046922] Clin Interv Aging 1(4): 451-66 (2006)
2009  
6
The treatment of wet age-related macular degeneration.
[19547647] Dtsch Arztebl Int 106(18): 312-7 (2009)
2007  
7
Age-related macular degeneration: a target for nanotechnology derived medicines.
[17722514] Int J Nanomedicine 2(1): 65-77 (2007)
2006  
8
Pegaptanib in the treatment of wet, age-related macular degeneration.
[17717967] Int J Nanomedicine 1(3): 263-8 (2006)
2008  
9
A preliminary model-based assessment of the cost-utility of a screening programme for early age-related macular degeneration.
[18513468] Health Technol Assess 12(27): iii-iv, ix-124 (2008)
2008  
10
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration: a systematic review and economic evaluation.
[18462575] Health Technol Assess 12(16): iii-iv, ix-201 (2008)
2003  
11
Clinical effectiveness and cost-utility of photodynamic therapy for wet age-related macular degeneration: a systematic review and economic evaluation.
[12709292] Health Technol Assess 7(9): v-vi, 1-98 (2003)
2007  
12
Molecular genetics of AMD and current animal models.
[17372852] Angiogenesis 10(2): 119-32 (2007)
2009  
13
The molecular genetic basis of age-related macular degeneration: an overview.
[20090206] J Genet 88(4): 425-49 (2009)
1998  
14
Age-related macular degeneration.
[9683972] Postgrad Med J 74(870): 203-7 (1998)
2000  
15
External beam radiotherapy in exudative age-related macular degeneration: a pooled analysis of phase I data.
[10817048] Br J Radiol 73(867): 305-13 (2000)
2010  
16
Newly diagnosed exudative age-related macular degeneration treated with pegaptanib sodium monotherapy in US community-based practices: medical chart review study.
[20144224] BMC Ophthalmol 10(): 2 (2010)
2007  
17
Use of intravitreal injection of triamcinolone acetonide in the treatment of age-related macular degeneration.
[17951899] Indian J Ophthalmol 55(6): 431-5 (2007)
2007  
18
Introduction, mechanism of action and rationale for anti-vascular endothelial growth factor drugs in age-related macular degeneration.
[17951895] Indian J Ophthalmol 55(6): 413-5 (2007)
2000  
19
New approaches in the management of choroidal neovascular membrane in age-related macular degeneration.
[11340884] Indian J Ophthalmol 48(4): 263-78 (2000)
2007  
20
An update on the genetics of age-related macular degeneration.
[17327825] Mol Vis 13(): 196-205 (2007)
1999  
21
Pathogenesis and Treatment of Age-Related Macular Degeneration: Current Knowledge and Leads for Future Research. June 4-6, 1998. Baltimore, Maryland, USA. Proceedings.
[10610222] Mol Vis 5(-): 24-35 (1999)
1999  
22
Changes in choriocapillaris and retinal pigment epithelium in age-related macular degeneration.
[10562659] Mol Vis 5(-): 35 (1999)
1999  
23
The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration.
[10562658] Mol Vis 5(-): 34 (1999)
1983  
24
Make your partnership work by adhering to a well-defined agreement.
[10262657] Can Doct 49(9): 79-80 (1983)
1983  
25
Are you prepared to invest in a medical office building?
[10262656] Can Doct 49(9): 67-9 (1983)
1999  
26
Cell death in age-related macular degeneration.
[10562655] Mol Vis 5(-): 31 (1999)
1999  
27
What can we learn about age-related macular degeneration from other retinal diseases?
[10562654] Mol Vis 5(-): 30 (1999)
1999  
28
The genetics of age-related macular degeneration.
[10562653] Mol Vis 5(-): 29 (1999)
1999  
29
Molecular composition of drusen as related to substructural phenotype.
[10562652] Mol Vis 5(-): 28 (1999)
1999  
30
Histopathology of age-related macular degeneration.
[10562651] Mol Vis 5(-): 27 (1999)
1999  
31
Epidemiology of age-related macular degeneration.
[10562650] Mol Vis 5(-): 26 (1999)
1999  
32
The natural history of geographic atrophy, the advanced atrophic form of age-related macular degeneration.
[10562649] Mol Vis 5(-): 25 (1999)
2009  
33
Treatment of neovascular age-related macular degeneration: Current therapies.
[19668562] Clin Ophthalmol 3(): 175-82 (2009)
2009  
34
Age-related macular degeneration: experimental and emerging treatments.
[19668561] Clin Ophthalmol 3(): 167-74 (2009)
2009  
35
Age-related macular degeneration: current treatments.
[19668560] Clin Ophthalmol 3(): 155-66 (2009)
2008  
36
Inhibitors of vascular endothelial growth factor (VEGF) in the management of neovascular age-related macular degeneration: a review of current practice.
[18637105] Clin Exp Optom 91(5): 427-37 (2008)
2007  
37
Age-related maculopathy in the light of ischaemia.
[17535365] Clin Exp Optom 90(4): 263-71 (2007)
2005  
38
Treatment of age-related macular degeneration.
[16255691] Clin Exp Optom 88(5): 322-34 (2005)
2005  
39
Objective functional assessment of age-related maculopathy: a special application for the multifocal electroretinogram.
[16255689] Clin Exp Optom 88(5): 304-12 (2005)
2005  
40
Assessment of age-related maculopathy using subjective vision tests.
[16255688] Clin Exp Optom 88(5): 292-303 (2005)
2001  
41
The genetics of age-related macular degeneration.
[12366313] Clin Exp Optom 84(4): 182-189 (2001)
2006  
42
Lesion morphology in age-related macular degeneration and its therapeutic significance.
[16769834] Arch Ophthalmol 124(6): 807-12 (2006)
2004  
43
Scanning laser entoptic perimetry for the detection of age-related macular degeneration.
[15534125] Arch Ophthalmol 122(11): 1647-51 (2004)
2007  
44
Guidance for the treatment of neovascular age-related macular degeneration.
[17655610] Acta Ophthalmol Scand 85(5): 486-94 (2007)
2007  
45
New therapies for neovascular age-related macular degeneration: critical appraisal of the current evidence.
[17244204] Acta Ophthalmol Scand 85(1): 6-20 (2007)
2006  
46
Age-related maculopathy and the impact of blue light hazard.
[16445433] Acta Ophthalmol Scand 84(1): 4-15 (2006)
2003  
47
Drusen maculopathy: a risk factor for AMD. Can we prevent visual loss?
[14510786] Acta Ophthalmol Scand 81(5): 427-9 (2003)
2003  
48
Recent advances in the treatment of exudative age-related macular degeneration, including transpupillary thermotherapy.
[12752045] Acta Ophthalmol Scand 81(2): 103-4 (2003)
2002  
49
Age-related maculopathy: pathogenetic features and new treatment modalities.
[11952478] Acta Ophthalmol Scand 80(2): 136-43 (2002)
2001  
50
Ocular perfusion and age-related macular degeneration.
[11284745] Acta Ophthalmol Scand 79(2): 108-15 (2001)
2010  
51
Identifying systemic safety signals following intravitreal bevacizumab: systematic review of the literature and the Canadian Adverse Drug Reaction Database.
[20628421] Can J Ophthalmol 45(3): 231-8 (2010)
2010  
52
Pharmacologic management of neovascular age-related macular degeneration: systematic review of economic evidence and primary economic evaluation.
[20628420] Can J Ophthalmol 45(3): 223-30 (2010)
2010  
53
Triple therapy for neovascular age-related macular degeneration (verteporfin photodynamic therapy, intravitreal dexamethasone, and intravitreal bevacizumab).
[20130708] Can J Ophthalmol 45(1): 36-40 (2010)
2008  
54
Age-related macular degeneration and low-vision rehabilitation: a systematic review.
[18347620] Can J Ophthalmol 43(2): 180-7 (2008)
2005  
55
Targeting angiogenesis, the underlying disorder in neovascular age-related macular degeneration.
[15947805] Can J Ophthalmol 40(3): 352-68 (2005)
2005  
56
Surgical management of age-related macular degeneration.
[15947804] Can J Ophthalmol 40(3): 341-51 (2005)
2005  
57
Rheopheresis for age-related macular degeneration: clinical results and putative mechanism of action.
[15947803] Can J Ophthalmol 40(3): 332-40 (2005)
2005  
58
Laser prophylaxis for age-related macular degeneration.
[15947802] Can J Ophthalmol 40(3): 320-31 (2005)
2005  
59
Preferred retinal loci and macular scotoma characteristics in patients with age-related macular degeneration.
[15947800] Can J Ophthalmol 40(3): 303-12 (2005)
2005  
60
Genetic aspects of age-related macular degeneration.
[15947798] Can J Ophthalmol 40(3): 288-92 (2005)
2005  
61
Age-related macular degeneration: economic burden and value-based medicine analysis.
[15947797] Can J Ophthalmol 40(3): 277-87 (2005)
2005  
62
Current concepts in macular degeneration: introduction.
[15947796] Can J Ophthalmol 40(3): 254-5 (2005)
2008  
63
[Update on the genetics of age-related macular degeneration].
[18772819] J Fr Ophtalmol 31(6 Pt 1): 630-7 (2008)
2007  
64
[Toward prevention of age-related macular degeneration].
[17568337] J Fr Ophtalmol 30(5): 449-55 (2007)
2003  
65
[Indocyanine green angiography in age-related macular degeneration].
[14586231] J Fr Ophtalmol 26(8): 854-63 (2003)
2007  
66
Towards a rational approach to combination therapy for neovascular age-related macular degeneration.
[17244655] Br J Ophthalmol 91(2): 130-1 (2007)
2006  
67
Evolving European guidance on the medical management of neovascular age related macular degeneration.
[16929063] Br J Ophthalmol 90(9): 1188-96 (2006)
2006  
68
Which treatment is best for which AMD patient?
[16424516] Br J Ophthalmol 90(2): 128-30 (2006)
2001  
69
The role of choroidal haemodynamic abnormalities in the pathogenesis of age related macular degeneration.
[11734506] Br J Ophthalmol 85(12): 1399-400 (2001)
2001  
70
Treatment of subfoveal choroidal neovascularisation in age related macular degeneration: focus on clinical application of verteporfin photodynamic therapy.
[11264143] Br J Ophthalmol 85(4): 483-95 (2001)
2000  
71
Foveal translocation for exudative age related macular degeneration.
[10729288] Br J Ophthalmol 84(4): 344-5 (2000)
2000  
72
Clinicopathological correlation in exudative age related macular degeneration: histological differentiation between classic and occult choroidal neovascularisation.
[10684831] Br J Ophthalmol 84(3): 239-43 (2000)
1999  
73
Photocoagulation of subfoveal choroidal neovascular membranes in age related macular degeneration: the impact of the macular photocoagulation study in the United Kingdom and Republic of Ireland.
[10502566] Br J Ophthalmol 83(10): 1103-4 (1999)
1999  
74
Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration.
[10413694] Br J Ophthalmol 83(8): 923-8 (1999)
1999  
75
Macular pigment and age related macular degeneration.
[10381676] Br J Ophthalmol 83(7): 867-77 (1999)
1998  
76
Alternative therapies in exudative age related macular degeneration.
[9930280] Br J Ophthalmol 82(12): 1441-3 (1998)
1996  
77
Laser treatment of soft drusen in age-related maculopathy.
[8664230] Br J Ophthalmol 80(1): 4 (1996)
1993  
78
Choroidal neovascularisation in age-related macular disease.
[7692955] Br J Ophthalmol 77(10): 614-5 (1993)
2003  
79
The genetics of inherited macular dystrophies.
[12960208] J Med Genet 40(9): 641-50 (2003)
2005  
80
[Hereditary macular dystrophies].
[15767907] J Fr Ophtalmol 28(1): 113-24 (2005)
2003  
81
1996  
82
Molecular genetics of macular dystrophies.
[8976733] Br J Ophthalmol 80(11): 1018-22 (1996)
2007  
83
Treatment of exudative age-related macular degeneration: many factors to consider.
[17659955] Am J Ophthalmol 144(2): 281-3 (2007)
2007  
84
New treatments for neovascular acute macular degeneration.
[17289688] BMJ 334(7588): 269-70 (2007)
2010  
85
Age-related macular degeneration: why should stroke physicians care?
[20150541] Stroke 41(4): 575-6 (2010)
2010  
86
Apolipoprotein B-containing lipoproteins in retinal aging and age-related macular degeneration.
[19797256] J Lipid Res 51(3): 451-67 (2010)
2010  
87
Therapeutic targets in age-related macular disease.
[20811159] J Clin Invest 120(9): 3033-41 (2010)
2007  
88
Age-related macular degeneration and recent developments: new hope for old eyes?
[17488857] Postgrad Med J 83(979): 301-7 (2007)
2010  
89
Age-related macular degeneration.
[20696800] CMAJ 182(16): 1759 (2010)
2006  
90
Age-related macular degeneration (AMD): pathogenesis and therapy.
[16845209] Pharmacol Rep 58(3): 353-63 (2006)
2006  
91
The role of optical coherence tomography (OCT) in the diagnosis and management of retinal angiomatous proliferation (RAP) in patients with age-related macular degeneration.
[16865194] Ann Acad Med Singapore 35(6): 420-4 (2006)
2010  
92
Age-related macular degeneration: genetic and environmental factors of disease.
[21045241] Mol Interv 10(5): 271-81 (2010)
2010  
93
Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications.
[20871825] Mediators Inflamm 2010(-): - (2010)
2006  
94
Anecortave acetate in the treatment of age-related macular degeneration.
[18046876] Clin Interv Aging 1(3): 237-46 (2006)
2008  
95
Age-related macular degeneration and the aging eye.
[18982917] Clin Interv Aging 3(3): 473-82 (2008)
2004  
96
Treatment of age-related macular degeneration.
[15056736] J R Soc Med 97(4): 166-9 (2004)
2010  
97
Endoplasmic reticulum stress as a primary pathogenic mechanism leading to age-related macular degeneration.
[20238041] Adv Exp Med Biol 664(): 403-9 (2010)
2010  
98
Animals as models of age-related macular degeneration: an imperfect measure of the truth.
[20382825] Vet Pathol 47(3): 396-413 (2010)
2010  
99
Concomitant bilateral intravitreal anti-VEGF injections for the treatment of exudative age-related macular degeneration.
[20689785] Clin Ophthalmol 4(-): 703-7 (2010)
2010  
100
Factors determining age-related macular degeneration: a current view.
[20440081] Medicina (Kaunas) 46(2): 89-94 (2010)
2007  
101
The economic implications of the use of anti-vascular endothelial growth factor drugs in age-related macular degeneration.
[17951901] Indian J Ophthalmol 55(6): 441-3 (2007)
2007  
102
The future implications and indications of anti-vascular endothelial growth factor therapy in ophthalmic practice.
[17951902] Indian J Ophthalmol 55(6): 445-50 (2007)
2008  
103
Recent advances in the treatment of age-related macular degeneration.
[18482482] Br J Gen Pract 58(550): 309-10 (2008)
2006  
104
Editorial: update on the modern management of wet age-related macular degeneration.
[16767199] Can J Ophthalmol 41(2): 133-8 (2006)
2008  
105
Ranibizumab: the evidence of its therapeutic value in neovascular age-related macular degeneration.
[21221192] Core Evid 2(4): 273-94 (2008)
2002  
106
Early detection and treatment of neovascular age-related macular degeneration.
[12002198] J Am Board Fam Pract 15(2): 142-52 (2002)
2011  
107
The significance of the complement system for the pathogenesis of age-related macular degeneration - current evidence and translation into clinical application.
[21127893] Graefes Arch Clin Exp Ophthalmol 249(2): 163-74 (2011)
2011  
108
Prevention of age-related macular degeneration.
[20862519] Int Ophthalmol 31(1): 73-82 (2011)
2005  
109
Melanization and phagocytosis: implications for age related macular degeneration.
[16030499] Mol Vis 11(-): 482-90 (2005)
2010  
110
Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).
[20206286] Prog Retin Eye Res 29(3): 169-90 (2010)
2009  
111
Molecular pathology of age-related macular degeneration.
[19026761] Prog Retin Eye Res 28(1): 1-18 (2009)
2011  
112
A review of ranibizumab clinical trial data in exudative age-related macular degeneration and how to translate it into daily practice.
[20938212] Ophthalmologica 225(2): 112-9 (2011)
2009  
113
A comparison of macular translocation with patch graft in neovascular age-related macular degeneration.
[19060287] Invest Ophthalmol Vis Sci 50(4): 1848-55 (2009)
2011  
114
Age-related macular degeneration: genetic and clinical findings.
[21175380] Clin Chem Lab Med 49(4): 601-16 (2011)

Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

All Medline data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.



Search PubMed and many other databases on the combined search terms

GG: macular degeneration
GG: macula degeneration

  • AMD Altersabhaengige Makuladegeneration

  • The BDOM Bibliographic Dictionary of Medicine is a curated collection of free medical articles tagged to concepts.
    Contents until 2011 are reviews from PubMed, contents flagged 'PMC' are regular articles from PubMed Central.
    Search BDOM
    Nephrology Collection
    Radiology Locator

    PubMedCentral monthly collection of free medical articles by major subject

    The framed wikipedia articles are from en.wikipedia.org and they are the actual versions; the first is from Nephropedia